SCHEMBL4352667

SCHEMBL4352667

N#Cc1cccc(Cl)c1Oc1cc([C@@H]2CNC(=O)C2)ccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 17/20 0.46
PDE4B Q07343 11/20 0.46
PDE4C Q08493 11/20 0.46
PDE4D Q08499 11/20 0.46
CYP3A4 P08684 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 2/20 0.40
VEGFA P15692 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALOX15 P16050 1/20 0.40
CREBBP Q92793 1/20 0.40
KDM4E B2RXH2 1/20 0.40
PDE5A O76074 1/20 0.40
TNF P01375 1/20 0.40
MAPK1 P28482 1/20 0.40
BLM P54132 1/20 0.40
PDE1A P54750 1/20 0.40
PDE1B Q01064 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5006229 1.00 PDE4A (0.46) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL14035849 0.79 PDE4A (0.45) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL559874 0.77 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL4189955 0.75 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DCYP1A2
SCHEMBL14036021 0.75 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DCYP1A2
SCHEMBL13922757 0.75 PDE4A (0.46) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL559787 0.74 MRGPRX4 (0.48) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL14035848 0.74 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL14035891 0.74 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL3549162 0.73 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1841425-A4 PHENYL-SUBSTITUTED PYRROLIDONES IRM LLC A DELWARE LTD LIABILIT (BM) 2009-02-18 EP disclosed
US-20080287516-A1 Phenyl-Substituted Pyrrolidones IRM LLC (BM) 2008-11-20 US disclosed
US-20080287516-A1 Phenyl-Substituted Pyrrolidones IRM LLC (BM) 2008-11-20 US disclosed
US-20080287516-A1 Phenyl-Substituted Pyrrolidones IRM LLC (BM) 2008-11-20 US disclosed
EP-1841425-A2 PHENYL-SUBSTITUTED PYRROLIDONES IRM LLC A Delware Limited Liability Company (BM) 2007-10-10 EP disclosed
WO-2006081554-A2 PHENYL-SUBSTITUTED PYRROLIDONES IRM LLC (BM) 2006-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287516-A1 Phenyl-Substituted Pyrrolidones MALT1, FKBP5, PREP PDE4A 1181/4885PDE4B 1238/4885PDE4C 1261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.